Showing results (211-220 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|July 25, 2018
Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patientsWan Zhu, Ling Xue, Hongwei Peng, et al.Pharmacogenomics|July 20, 2018
Association of ABCC2 polymorphism and gender with high-density lipoprotein cholesterol response to simvastatinNa Liu, Guihua Yang, Mei Hu, et al.Pharmacogenomics|July 21, 2018
Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directionsMelissa D Klein, Craig R Lee, George A StoufferPharmacogenomics|May 5, 2017
OCT1 genetic variants are associated with postoperative morphine-related adverse effects in childrenRajiv Balyan, Xue Zhang, Vidya Chidambaran, et al.Pharmacogenomics|May 5, 2017
Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasisMaría C Ovejero-Benito, Rocío Prieto-Pérez, Mar Llamas-Velasco, et al.Pharmacogenomics|April 29, 2017
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patientsJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.Pharmacogenomics|April 29, 2017
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.Pharmacogenomics|May 24, 2018
RICTOR gene amplification is correlated with metastasis and therapeutic resistance in triple-negative breast cancerSaid El Shamieh, Fatima Saleh, Salim Moussa, et al.Pharmacogenomics|May 24, 2018
Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplificationRaymon Vijzelaar, Mariana R Botton, Lisette Stolk, et al.Pharmacogenomics|September 21, 2016
Patient experiences with pharmacogenetic testing in a primary care settingSusanne B Haga, Rachel Mills, Jivan Moaddeb, et al.Pageof 276